These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 22561297

  • 1. Cardiac mTOR protects the heart against ischemia-reperfusion injury.
    Aoyagi T, Kusakari Y, Xiao CY, Inouye BT, Takahashi M, Scherrer-Crosbie M, Rosenzweig A, Hara K, Matsui T.
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H75-85. PubMed ID: 22561297
    [Abstract] [Full Text] [Related]

  • 2. Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.
    Aoyagi T, Higa JK, Aoyagi H, Yorichika N, Shimada BK, Matsui T.
    Am J Physiol Heart Circ Physiol; 2015 Jun 15; 308(12):H1530-9. PubMed ID: 25888508
    [Abstract] [Full Text] [Related]

  • 3. Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway.
    Zhou Y, Fang H, Lin S, Shen S, Tao L, Xiao J, Li X.
    Cell Physiol Biochem; 2015 Jun 15; 37(2):454-64. PubMed ID: 26315320
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG, Yu H, De Boer RA, van de Kolk CW, van de Sluis B, Van Deursen JM, Van Gilst WH, Silljé HH, Westenbrink BD.
    Cardiovasc Res; 2016 Aug 01; 111(3):217-26. PubMed ID: 27302402
    [Abstract] [Full Text] [Related]

  • 5. mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury.
    Shimada BK, Yorichika N, Higa JK, Baba Y, Kobayashi M, Aoyagi T, Suhara T, Matsui T.
    Physiol Rep; 2021 Mar 01; 9(6):e14807. PubMed ID: 33769701
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
    Zhou X, Fan GC, Ren X, Waggoner JR, Gregory KN, Chen G, Jones WK, Kranias EG.
    Cardiovasc Res; 2007 Aug 01; 75(3):487-97. PubMed ID: 17499229
    [Abstract] [Full Text] [Related]

  • 7. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.
    Song X, Kusakari Y, Xiao CY, Kinsella SD, Rosenberg MA, Scherrer-Crosbie M, Hara K, Rosenzweig A, Matsui T.
    Am J Physiol Cell Physiol; 2010 Dec 01; 299(6):C1256-66. PubMed ID: 20861467
    [Abstract] [Full Text] [Related]

  • 8. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
    Pozo-Navas B, Stessel H, Wölkart G, Brunner F.
    J Pharmacol Exp Ther; 2006 Nov 01; 319(2):729-38. PubMed ID: 16857730
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
    Das A, Salloum FN, Filippone SM, Durrant DE, Rokosh G, Bolli R, Kukreja RC.
    Basic Res Cardiol; 2015 May 01; 110(3):31. PubMed ID: 25911189
    [Abstract] [Full Text] [Related]

  • 10. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
    Zhong B, Wang DH.
    Am J Physiol Regul Integr Comp Physiol; 2009 Dec 01; 297(6):R1681-90. PubMed ID: 19812353
    [Abstract] [Full Text] [Related]

  • 11. HSPA12B Attenuated Acute Myocardial Ischemia/reperfusion Injury via Maintaining Endothelial Integrity in a PI3K/Akt/mTOR-dependent Mechanism.
    Kong Q, Dai L, Wang Y, Zhang X, Li C, Jiang S, Li Y, Ding Z, Liu L.
    Sci Rep; 2016 Sep 20; 6():33636. PubMed ID: 27644317
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Brunner F, Maier R, Andrew P, Wölkart G, Zechner R, Mayer B.
    Cardiovasc Res; 2003 Jan 20; 57(1):55-62. PubMed ID: 12504814
    [Abstract] [Full Text] [Related]

  • 13. Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.
    Sasaki T, Shishido T, Kadowaki S, Kitahara T, Suzuki S, Katoh S, Funayama A, Netsu S, Watanabe T, Goto K, Takeishi Y, Kubota I.
    Heart Vessels; 2014 Jan 20; 29(1):110-8. PubMed ID: 23719772
    [Abstract] [Full Text] [Related]

  • 14. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
    Zhang J, Jiang H, Liu DH, Wang GN.
    Eur Rev Med Pharmacol Sci; 2019 Aug 20; 23(15):6736-6743. PubMed ID: 31378917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion.
    Zhai P, Sciarretta S, Galeotti J, Volpe M, Sadoshima J.
    Circ Res; 2011 Aug 19; 109(5):502-11. PubMed ID: 21737790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.
    Wang L, Quan N, Sun W, Chen X, Cates C, Rousselle T, Zhou X, Zhao X, Li J.
    Cardiovasc Res; 2018 May 01; 114(6):805-821. PubMed ID: 29409011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.